Press Release. F2G and Shionogi Announce Positive Topline Results from Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed ...
Innovation. Clarity. Execution. I News News. Keep up to date with our latest press releases Media Contact: adventls@brackendaleconsulting.com The companie ...
Innovation. Clarity. Execution. I Team Team. Learn more about our team We are a highly experienced team with a long-standing track record of entrepreneuri ...
Innovation. Clarity. Execution. I About About. Investment Approach. The journey from innovative science to an approved medicine or product is long, diffic ...
Innovation. Clarity. Execution. I Contact Contact. Advent Life Sciences LLP 27 Fitzroy Square London W1T 6ES T. +44 (0)20 7932 2100 E. contact@adventls.co ...
Venture Capital Firm I Home Innovation. Clarity. Execution. A Venture Capital Firm for Visionary Innovators. Advent Life Sciences is one of the leading tr ...